Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

This study will validate a previously developed pediatric prognostic biomarker algorithm
aimed at improving prediction of risk for the later development of chronic graft-versus-host
disease (cGvHD) in children and young adults undergoing allogeneic hematopoietic stem cell
transplant.

By developing an early risk stratification of patients into low-, intermediate-, and
high-risk for future cGvHD development (based upon their biomarker profile, before the onset
of cGvHD), pre-emptive therapies aimed at preventing the onset of cGvHD can be developed
based upon an individual's biological risk profile.

This study will also continue research into diagnostic biomarkers of cGvHD, and begin work
into biomarker models that predict clinical response to cGvHD therapies.
Not Available
N/A
Kitko, Carrie
NCT04372524
VICCPED2183

Laryngeal Cancer Treatment Decision-Making: A Conjoint Analysis of Post-Treatment Priorities

Not Available
N/A
Topf, Michael
VICCHN2201


TYRX Health Pocket

Not Available
Ellis, Christopher
CRE-ARR0012

Aveir DR i2i Study - Aveir Dual-Chamber Leadless i2i IDE Study

Not Available
II
Richardson, Travis
CRE-ARR0013

CONFORM Pivotal - An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion

Not Available
II
Ellis, Christopher
CRE-ARR0011

Sphere- Treatment of Persistent Atrial Fibrillation with the Sphere -9- mapping and ablation cathether and the AFFERA Mapping and Ablation system

Not Available
II
Richardson, Travis
CRE-ARR0015


LESS VT- Flexibility Sensor Enabled Substrate Targeted Ablation for teh Reduction of VT (LESS VT) Study

Not Available
II
Tandri, Harikrishna
CRE-ARR0016

VANISH 2- Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2

Not Available
III
Kanagasundram, Arvindh
CRE-CHF0001

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.